Profile
John F.
Neylan currently works at Akari Therapeutics Plc, as Chief Medical Officer & Executive Vice President from 2022.
Dr. Neylan also formerly worked at Advances In Kidney Disease & Health, as Director, Keryx Biopharmaceuticals, Inc., as Chief Medical Officer & Senior Vice President from 2015 to 2018, Genzyme Corp., as Senior Vice President-Clinical Development, Emory University, as Professor, the University of California, Davis, as Assistant Professor, Wyeth Research, as Vice President-Research & Development from 2000 to 2008, The American Society of Transplantation, as President, and Angion Biomedica Corp., as Chief Medical Officer & Senior Vice President.
Dr. Neylan received his undergraduate degree from Duke University and doctorate degree from Rush Medical College.
John Neylan active positions
| Companies | Position | Start |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Chief Tech/Sci/R&D Officer | 2022-11-07 |
Former positions of John Neylan
| Companies | Position | End |
|---|---|---|
| ANGN BIOM | Chief Tech/Sci/R&D Officer | 2022-08-14 |
| KERYX BIOPHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 2018-12-11 |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Discovers and develops platforms encompassing pharmaceuticals | Corporate Officer/Principal | 2008-04-30 |
Advances In Kidney Disease & Health
Advances In Kidney Disease & Health Miscellaneous Commercial ServicesCommercial Services Provides awareness on kidney and urinary tract diseases | Director/Board Member | - |
The American Society of Transplantation
The American Society of Transplantation Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides transplantation and patient care services | President | - |
Training of John Neylan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emory University
Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advances In Kidney Disease & Health
Advances In Kidney Disease & Health Miscellaneous Commercial ServicesCommercial Services Provides awareness on kidney and urinary tract diseases | Commercial Services |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Discovers and develops platforms encompassing pharmaceuticals | Commercial Services |
The American Society of Transplantation
The American Society of Transplantation Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides transplantation and patient care services | Commercial Services |
Rush Medical College
Rush Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Angion Biomedica Corp.
Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products | Health Technology |
Akari Therapeutics Plc
Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- John Neylan
















